FDA Extends Roflumilast’s AD Approval to Young Children

The approval is for children ages 2-5 with mild-to-moderate atopic dermatitis.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-extends-topical-roflumilasts-atopic-dermatitis-approval-2025a1000quo?src=rss

Author :

Publish date : 2025-10-06 20:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

FDA Extends Roflumilast’s AD Approval to Young Children

Galaxies fling out matter much more violently than we thought

These Physicians Are More Likely to Leave Clinical Practice

Related Posts

‘It’s Not How a Responsible Scientist Acts’: What We Heard This Week

Pain Patients Often Feel Out of Options. Acupuncture Hides in Plain Sight.

Trump and Republicans Once More Face a Tough Political Fight Over Obamacare

Extinct animals in Prehistoric Planet: Ice Age make it a must-watch

‘It sounds dramatic – but singing class saved by life’

Is Chemo Driving Late Cardiac Events in Older Cancer Survivors?

‘It’s Not How a Responsible Scientist Acts’: What We Heard This Week

Pain Patients Often Feel Out of Options. Acupuncture Hides in Plain Sight.

Trump and Republicans Once More Face a Tough Political Fight Over Obamacare

Extinct animals in Prehistoric Planet: Ice Age make it a must-watch

‘It sounds dramatic – but singing class saved by life’

Is Chemo Driving Late Cardiac Events in Older Cancer Survivors?

Potassium in Patients with ICDs; mRNA Flu Vaccine; Canceled NIH Funding for Trials

The FDA Commissioner Is Missing the Point of Advisory Committees

Categories

Archives